This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects
Clinical trial NCT01706315 · COMPLETED
Trial details
- NCT number
- NCT01706315
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-17
- Primary completion
- 2013-12-13
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.